Recon: FDA approves first generic version of AbbVie’s Restasis; Biden relaunches cancer ‘moonshot’
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy